Most adults with systemic lupus erythematosus (SLE) are not at increased risk of hospitalization from COVID-19 due to medications used to dampen their altered immune system, the cause of their disease. Nor are most people with more common types of arthritis, such as rheumatoid, psoriatic and spondyloarthritis, at greater risk of hospitalization from COVID-19, a...
Tag: <span>treatments for psoriatic arthritis</span>
Imaging tests help reveal heart risks in patients with psoriatic disease
by Wiley Patients with psoriasis and psoriatic arthritis—collectively termed psoriatic disease—face increased heart risks. A new study published in Arthritis & Rheumatology indicates that ultrasound imaging of the carotid arteries can reveal the extent to which patients’ arteries are clogged and also indicate their risk of experiencing future cardiovascular events. The findings suggest that combining such...
New effective treatments for psoriatic arthritis patients
New agents working on different inflammatory aspects of PsA are needed in the treatment of PsA patients living with this chronic immune-mediated disease, which involves both joint and skin symptoms. In the first study, in patients with active PsA who had not previously been prescribed an anti-TNF treatment, tofacitinib (an oral Janus kinase inhibitor under...